SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Izzy who wrote (3430)12/27/1997 12:04:00 AM
From: Mr. Pink  Read Replies (2) of 6136
 
Does anyone know what the current # of Viracept prescriptions sold per week is? How much does Agouron get paid on average per prescription? Is the rate of growth of new Viracept prescriptions still increasing exponentially? Finally, what is the cost of production per prescription?

These #'s would go a long way towards getting some sort of a numerical handle on AGPH's prospects.

Someone posted that the price of the stock might go to 60 over the next 12 months. I think predicting the earnings of AGPH 12 mos. from now would be more useful than guesstimating the stock price.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext